TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab (Q59565353)
Jump to navigation
Jump to search
scientific article published on 04 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab |
scientific article published on 04 March 2011 |
Statements
TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab (English)
Stefan Glück
Melanie Royce
Eli Avisar
Lin Wu
Jeffrey S Ross
Edward F McKenna